IDEAYA Biosciences to Participate in Citi's 2023 Virtual Oncology Leadership Summit
IDEAYA Biosciences (NASDAQ: IDYA), a precision medicine oncology company, will participate in Citi's 2023 Virtual Oncology Leadership Summit on February 21, 2023, at 9:00 AM ET. The event features a fireside chat with President and CEO Yujiro S. Hata, hosted by Dr. Yigal D. Nochomovitz. Investors can access a live audio webcast via IDEAYA's website, with a replay available for 30 days after the event.
IDEAYA focuses on synthetic lethality and targeted therapeutics, using molecular diagnostics to identify patient populations that benefit from its innovative therapies. The company is dedicated to advancing precision medicine in oncology.
- None.
- None.
Citi's 2023 Virtual Oncology Leadership Summit
Fireside chat with
A live audio webcast of the event will be available, as permitted by conference host, at the "Investors/ Events" section of the IDEAYA website at https://ir.ideayabio.com/events. A replay of the webcast will be accessible for 30 days following the live event.
About
IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's Quarterly Report on Form 10-Q filed on
Investor and Media Contact
Senior Vice President and Chief Financial Officer
investor@ideayabio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-citis-2023-virtual-oncology-leadership-summit-301748381.html
SOURCE
FAQ
When will IDEAYA Biosciences participate in Citi's 2023 Virtual Oncology Leadership Summit?
Who is hosting the fireside chat at the Citi's oncology summit featuring IDEAYA?
How can I access the IDEAYA webcast from the oncology summit?
What is the focus of IDEAYA Biosciences?
Is there a replay available for the IDEAYA biosciences summit event?
